BET’s Bob Johnson; Tesla’s Refunds; Target’s Makeup Counters
In the wake of Pfizer’s positive vaccine news, markets are rallying on hopes of a light at the end of the pandemic tunnel. BET and RLJ Companies founder Bob Johnson is relieved by the news but looking...
10 Nov 202029min
Lessons from Election Market History; “The Black Swan” Author Nassim Taleb
Ed Clissold, market strategist for Ned Davis Research Group, puts this week’s election in perspective with market and election data going back to 1900. Historically, a Republican incumbent victory pro...
9 Nov 202034min
Breakthrough: Pfizer's Vaccine & “A Great Day for Humanity” with CEO Albert Bourla
In what Pfizer CEO Albert Bourla calls “likely the most significant medical advancement in the last 100 years,” BioNtech and Pfizer’s Covid-19 vaccine may prove to be more than 90% effective in preven...
9 Nov 202038min
Election Day, Continued: Leon Cooperman, Uber CEO, & Arthur Brooks
Legendary investor Leon Cooperman explains his approach to markets amid the ongoing Presidential vote and the Federal Reserve’s approach to stabilizing the economy. The billionaire explains his person...
6 Nov 202037min
“It’s Got to End at Some Point, for the Good of the Country”
As 2020 election results trickle in, Al Gore’s running mate former Senator Joe Lieberman reflects on the 34 controversial days between Election Day in 2000 and Gore’s final concession. His lessons fro...
5 Nov 202035min
He’s a Political Force: Barry Diller & David Rubenstein, the Morning After
As votes are counted across the country, David Rubenstein, co-founder and co-executive chairman of The Carlyle Group, expects market jitters to continue until a clear winner emerges. He and IAC Chairm...
4 Nov 202030min
Election Day 2020: The United States of Anxiety
Election Day 2020 is finally here. At this culmination of America’s anxieties, former Facebook Chief Security Officer Alex Stamos discusses social media’s strategies and obligations to curb misinforma...
3 Nov 202035min
Counting on Confidence: Vaccines with Dr. Atul Gawande & Investor Sentiment Beyond Election Day
Dr. Atul Gawande, Chairman of Haven, surgeon, and staff writer for The New Yorker, shares his expectations for coronavirus vaccine supply and American confidence in preventative drugs. CNBC’s Steve Li...
30 Okt 202032min
